# Recent Clinical Advances in Cardiovascular and Metabolic Medicine New research highlights innovations in heart failure, hypertension, and surgical intervention techniques. - **Source:** [MedPage Today](https://www.medpagetoday.com) - **Published:** 2026-11-10 - **Topic:** [health](https://brifing.si/c/health) - **Original article:** - **On Brifing:** https://brifing.si/s/2850dc63-f169-419f-b118-1910560f8abe ## Air Quality and Metabolism A sham-controlled trial conducted by NYU Langone Health indicates that using high-efficiency particulate air filters in bedrooms can improve blood sugar control. This finding suggests that environmental factors like indoor air quality may play a more significant role in metabolic regulation than previously understood, offering a non-pharmacological intervention for patients. ## AI-Driven Hypertension Detection A validation study demonstrated that a smartwatch-based artificial intelligence algorithm can detect hypertension with 65.8% sensitivity and 90.0% specificity. This technology represents a shift toward continuous, non-invasive monitoring of blood pressure, potentially allowing for earlier clinical intervention and better management of cardiovascular risks in the general ambulatory population. ## ECMO in Emergency Care A Dutch trial published in the New England Journal of Medicine found that equipping emergency medical services with extracorporeal CPR technology significantly increases survival rates. Specifically, the use of venoarterial extracorporeal membrane oxygenation for patients suffering from refractory out-of-hospital cardiac arrest provides a critical window for life-saving medical intervention. ## Cardiogenic Shock Classification The Society for Cardiovascular Angiography and Interventions has updated its SHOCK classification system to better reflect clinical reality. The new framework emphasizes perfusion, serial reassessment, and clinical trajectory, providing clinicians with a more nuanced tool to describe the severity of cardiogenic shock and guide appropriate therapeutic decisions for critical patients. ## Pharmacological Trial Outcomes Recent trials show mixed results for cardiovascular medications. IV cangrelor failed to meet noninferiority to oral ticagrelor for acute myocardial infarction outcomes. Conversely, a target trial emulation study found that evolocumab was associated with a 20% lower rate of myocardial infarctions over four years compared to ezetimibe, highlighting significant long-term efficacy. ## Hypertension Treatment Innovations Researchers at Queen Mary University of London report promising early-stage data for extended aldosterone synthase inhibition to achieve remission from primary aldosteronism. Additionally, Mineralys Therapeutics released 48-week results for lorundrostat, supporting its use in treating uncontrolled or resistant hypertension, marking a potential advancement in managing difficult-to-control blood pressure cases. ## Predictive Heart Failure Monitoring The HearO smartphone application utilizes daily voice recordings to predict heart failure events weeks before they occur in ambulatory patients. This digital health tool allows for proactive management of heart failure, potentially reducing hospital readmissions by enabling clinicians to adjust treatment plans before a patient experiences a severe clinical decline. ## Complex Surgical Interventions A case report in the European Heart Journal details an 88-year-old woman who underwent a successful redo transcatheter aortic valve replacement. This procedure, described as a valve-within-a-valve-within-a-valve, demonstrates the evolving capabilities of minimally invasive cardiac surgery to treat elderly patients who have previously received multiple valve replacements over time. ## Sources covering this story - https://www.medpagetoday.com/cardiology/generalcardiology/123814 — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._